Catalyst Wire Dossier Catalyst Wire Dossier

Kinisoquin™

· Quercis Pharma AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kinisoquin™, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 3]

See pricing